US approves new drug against Alzheimer's

2021-06-09T00:26:42.719Z

This drug, named Aduhelm, is the first authorized by the United States Medicines Agency since 2003 The US regulator announced Monday authorizing a new drug against Alzheimer's disease, characterized by progressive loss of memory and intellectual capacity, for the first time in nearly two decades. "This clearance is significant in many ways," the US Drugs Agency (FDA) said in a statement. The drug, named Aduhelm and produced by the pharmaceutical company Biogen, "is the first approved treatment